Report Code: 11612 | Available Format: PDF | Pages: 379
Wound Care Biologics Market Research Report: By Product (Skin Substitutes, Growth Factors, Collagen-Based, Cell-Based, Enzyme-Based), Durability (Permanent, Temporary), Formulation (Topical), Application (Chronic, Acute), End-User (Hospitals & Specialty Clinics, ASCs, Home Care), Geographical Outlook (U.S., Canada, Germany, France, U.K., Italy, Spain, China, Japan, India, Australia, Mexico, Brazil, Saudi Arabia, South Africa, Israel) - Industry Size and Share Analysis and Growth Forecast to 2024
- Report Code: 11612
- Available Format: PDF
- Pages: 379
- Report Description
- Table of Contents
- Market Segmentation
- Request Free Sample
Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.3.1 Market Segmentation by Product
1.3.2 Market Segmentation by Durability
1.3.3 Market Segmentation by Formulation
1.3.4 Market Segmentation by Application
1.3.5 Market Segmentation by End User
1.3.6 Market Segmentation by Geography
1.3.7 Analysis Period
1.3.8 Market Data Reporting Unit
1.3.8.1 Value
1.4 Key Stakeholders
Chapter 2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.2.1 Breakdown of Primary Research Respondents
2.2.1.1 By region
2.2.1.2 By industry participant
2.2.1.3 By company type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Assumptions for the Study
Chapter 3. Executive Summary
Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Product
4.1.1.1 Skin substitutes
4.1.1.1.1 Human donor tissue-derived
4.1.1.1.2 Acellular animal-derived
4.1.1.1.3 Biosynthetic
4.1.1.2 Growth factors
4.1.1.2.1 PDGF
4.1.1.2.2 FGF
4.1.1.2.3 EGF
4.1.1.2.4 Transforming growth factor-beta (TGF-β)
4.1.1.2.5 Insulin-like growth factors (IGF)
4.1.1.2.6 Others
4.1.1.3 Collagen-based
4.1.1.4 Cell-based
4.1.1.4.1 Viable
4.1.1.4.2 Non-viable
4.1.1.5 Enzyme-based
4.1.1.6 Others
4.1.2 By Durability
4.1.2.1 Permanent
4.1.2.2 Temporary
4.1.3 By Formulation
4.1.3.1 Topical
4.1.3.2 Others
4.1.4 By Application
4.1.4.1 Chronic
4.1.4.1.1 DFU
4.1.4.1.2 Pressure ulcers
4.1.4.1.3 VLU
4.1.4.2 Acute
4.1.4.2.1 Surgical, traumatic, and burn injuries
4.1.4.2.2 Others
4.1.5 By End User
4.1.5.1 Hospitals & specialty clinics
4.1.5.1.1 Inpatient
4.1.5.1.2 Outpatient
4.1.5.2 ASCs
4.1.5.3 Home care
4.2 Market Dynamics
4.2.1 Trends
4.2.2 Drivers
4.2.3 Restraints
4.2.4 Opportunities
4.3 Porter’s Five Forces Analysis
4.4 Regulatory Overview
4.5 List of Wound Care Societies
Chapter 5. Global Market Size and Forecast
5.1 By Product
5.1.1 Skin Substitutes Market, by Type
5.1.2 Growth Factors Market, by Type
5.1.3 Cell-Based Wound Care Biologics Market, by Type
5.2 By Durability
5.3 By Formulation
5.4 By Application
5.4.1 Wound Care Biologics Market for Acute Wounds, by Type
5.4.2 Wound Care Biologics Market for Chronic Wounds, by Type
5.5 By End User
5.5.1 Wound Care Biologics Market in Hospitals & Specialty Clinics, by Type
5.6 By Region
Chapter 6. North America Market Size and Forecast
6.1 By Product
6.1.1 Skin Substitutes Market, by Type
6.1.2 Growth Factors Market, by Type
6.1.3 Cell-Based Wound Care Biologics Market, by Type
6.2 By Durability
6.3 By Formulation
6.4 By Application
6.4.1 Wound Care Biologics Market for Acute Wounds, by Type
6.4.2 Wound Care Biologics Market for Chronic Wounds, by Type
6.5 By End User
6.5.1 Wound Care Biologics Market in Hospitals & Specialty Clinics, by Type
6.6 By Country
6.6.1 U.S. Market Size and Forecast
6.6.1.1 By product
6.6.1.1.1 Skin substitutes market, by type
6.6.1.1.2 Growth factors market, by type
6.6.1.1.3 Cell-based wound care biologics market, by Type
6.6.1.2 By durability
6.6.1.3 By formulation
6.6.1.4 By application
6.6.1.4.1 Wound care biologics market for acute wounds, by type
6.6.1.4.2 Wound care biologics market for chronic wounds, by type
6.6.1.5 By end user
6.6.1.5.1 Wound care biologics market in hospitals & specialty clinics, by type
6.6.2 Canada Market Size and Forecast
6.6.2.1 By product
6.6.2.1.1 Skin substitutes market, by type
6.6.2.1.2 Growth factors market, by type
6.6.2.1.3 Cell-based wound care biologics market, by type
6.6.2.2 By durability
6.6.2.3 By formulation
6.6.2.4 By application
6.6.2.4.1 Wound care biologics market for acute wounds, by type
6.6.2.4.2 Wound care biologics market for chronic wounds, by type
6.6.2.5 By end user
6.6.2.5.1 Wound care biologics market in hospitals & specialty clinics, by type
Chapter 7. Europe Market Size and Forecast
7.1 By Product
7.1.1 Skin Substitutes Market, by Type
7.1.2 Growth Factors Market, by Type
7.1.3 Cell-Based Wound Care Biologics Market, by Type
7.2 By Durability
7.3 By Formulation
7.4 By Application
7.4.1 Wound Care Biologics Market for Acute Wounds, by Type
7.4.2 Wound Care Biologics Market for Chronic Wounds, by Type
7.5 By End User
7.5.1 Wound Care Biologics Market in Hospitals & Specialty Clinics, by Type
7.6 By Country
7.6.1 Germany Market Size and Forecast
7.6.1.1 By product
7.6.1.1.1 Skin substitutes market, by type
7.6.1.1.2 Growth factors market, by type
7.6.1.1.3 Cell-based wound care biologics market, by type
7.6.1.2 By durability
7.6.1.3 By formulation
7.6.1.4 By application
7.6.1.4.1 Wound care biologics market for acute wounds, by type
7.6.1.4.2 Wound care biologics market for chronic wounds, by type
7.6.1.5 By end user
7.6.1.5.1 Wound care biologics market in hospitals & specialty clinics, by type
7.6.2 France Market Size and Forecast
7.6.2.1 By product
7.6.2.1.1 Skin substitutes market, by type
7.6.2.1.2 Growth factors market, by type
7.6.2.1.3 Cell-based wound care biologics market, by type
7.6.2.2 By durability
7.6.2.3 By formulation
7.6.2.4 By application
7.6.2.4.1 Wound care biologics market for acute wounds, by type
7.6.2.4.2 Wound care biologics market for chronic wounds, by type
7.6.2.5 By end user
7.6.2.5.1 Wound care biologics market in hospitals & specialty clinics, by type
7.6.3 U.K. Market Size and Forecast
7.6.3.1 By product
7.6.3.1.1 Skin substitutes market, by type
7.6.3.1.2 Growth factors market, by type
7.6.3.1.3 Cell-based wound care biologics market, by type
7.6.3.2 By durability
7.6.3.3 By formulation
7.6.3.4 By application
7.6.3.4.1 Wound care biologics market for acute wounds, by type
7.6.3.4.2 Wound care biologics market for chronic wounds, by type
7.6.3.5 By end user
7.6.3.5.1 Wound care biologics market in hospitals & specialty clinics, by type
7.6.4 Italy Market Size and Forecast
7.6.4.1 By product
7.6.4.1.1 Skin substitutes market, by type
7.6.4.1.2 Growth factors market, by type
7.6.4.1.3 Cell-based wound care biologics market, by type
7.6.4.2 By durability
7.6.4.3 By formulation
7.6.4.4 By application
7.6.4.4.1 Wound care biologics market for acute wounds, by type
7.6.4.4.2 Wound care biologics market for chronic wounds, by type
7.6.4.5 By end user
7.6.4.5.1 Wound care biologics market in hospitals & specialty clinics, by type
7.6.5 Spain Market Size and Forecast
7.6.5.1 By product
7.6.5.1.1 Skin substitutes market, by type
7.6.5.1.2 Growth factors market, by type
7.6.5.1.3 Cell-based wound care biologics market, by type
7.6.5.2 By durability
7.6.5.3 By formulation
7.6.5.4 By application
7.6.5.4.1 Wound care biologics market for acute wounds, by type
7.6.5.4.2 Wound care biologics market for chronic wounds, by type
7.6.5.5 By end user
7.6.5.5.1 Wound care biologics market in hospitals & specialty clinics, by type
Chapter 8. APAC Market Size and Forecast
8.1 By Product
8.1.1 Skin Substitutes Market, by Type
8.1.2 Growth Factors Market, by Type
8.1.3 Cell-Based Wound Care Biologics Market, by Type
8.2 By Durability
8.3 By Formulation
8.4 By Application
8.4.1 Wound Care Biologics Market for Acute Wounds, by Type
8.4.2 Wound Care Biologics Market for Chronic Wounds, by Type
8.5 By End User
8.5.1 Wound Care Biologics Market in Hospitals & Specialty Clinics, by Type
8.6 By Country
8.6.1 China Market Size and Forecast
8.6.1.1 By product
8.6.1.1.1 Skin substitutes market, by type
8.6.1.1.2 Growth factors market, by type
8.6.1.1.3 Cell-based wound care biologics market, by type
8.6.1.2 By durability
8.6.1.3 By formulation
8.6.1.4 By application
8.6.1.4.1 Wound care biologics market for acute wounds, by type
8.6.1.4.2 Wound care biologics market for chronic wounds, by type
8.6.1.5 By end user
8.6.1.5.1 Wound care biologics market in hospitals & specialty clinics, by type
8.6.2 Japan Market Size and Forecast
8.6.2.1 By product
8.6.2.1.1 Skin substitutes market, by type
8.6.2.1.2 Growth factors market, by type
8.6.2.1.3 Cell-based wound care biologics market, by type
8.6.2.2 By durability
8.6.2.3 By formulation
8.6.2.4 By application
8.6.2.4.1 Wound care biologics market for acute wounds, by type
8.6.2.4.2 Wound care biologics market for chronic wounds, by type
8.6.2.5 By end user
8.6.2.5.1 Wound care biologics market in hospitals & specialty clinics, by type
8.6.3 India Market Size and Forecast
8.6.3.1 By product
8.6.3.1.1 Skin substitutes market, by type
8.6.3.1.2 Growth factors market, by type
8.6.3.1.3 Cell-based wound care biologics market, by type
8.6.3.2 By durability
8.6.3.3 By formulation
8.6.3.4 By application
8.6.3.4.1 Wound care biologics market for acute wounds, by type
8.6.3.4.2 Wound care biologics market for chronic wounds, by type
8.6.3.5 By end user
8.6.3.5.1 Wound care biologics market in hospitals & specialty clinics, by type
8.6.4 Australia Market Size and Forecast
8.6.4.1 By product
8.6.4.1.1 Skin substitutes market, by type
8.6.4.1.2 Growth factors market, by type
8.6.4.1.3 Cell-based wound care biologics market, by type
8.6.4.2 By durability
8.6.4.3 By formulation
8.6.4.4 By application
8.6.4.4.1 Wound care biologics market for acute wounds, by type
8.6.4.4.2 Wound care biologics market for chronic wounds, by type
8.6.4.5 By end user
8.6.4.5.1 Wound care biologics market in hospitals & specialty clinics, by type
Chapter 9. LATAM Market Size and Forecast
9.1 By Product
9.1.1 Skin Substitutes Market, by Type
9.1.2 Growth Factors Market, by Type
9.1.3 Cell-Based Wound Care Biologics Market, by Type
9.2 By Durability
9.3 By Formulation
9.4 By Application
9.4.1 Wound Care Biologics Market for Acute Wounds, by Type
9.4.2 Wound Care Biologics Market for Chronic Wounds, by Type
9.5 By End User
9.5.1 Wound Care Biologics Market in Hospitals & Specialty Clinics, by Type
9.6 By Country
9.6.1 Mexico Market Size and Forecast
9.6.1.1 By product
9.6.1.1.1 Skin substitutes market, by type
9.6.1.1.2 Growth factors market, by type
9.6.1.1.3 Cell-based wound care biologics market, by type
9.6.1.2 By durability
9.6.1.3 By formulation
9.6.1.4 By application
9.6.1.4.1 Wound care biologics market for acute wounds, by type
9.6.1.4.2 Wound care biologics market for chronic wounds, by type
9.6.1.5 By end user
9.6.1.5.1 Wound care biologics market in hospitals & specialty clinics, by type
9.6.2 Brazil Market Size and Forecast
9.6.2.1 By product
9.6.2.1.1 Skin substitutes market, by type
9.6.2.1.2 Growth factors market, by type
9.6.2.1.3 Cell-based wound care biologics market, by type
9.6.2.2 By durability
9.6.2.3 By formulation
9.6.2.4 By application
9.6.2.4.1 Wound care biologics market for acute wounds, by type
9.6.2.4.2 Wound care biologics market for chronic wounds, by type
9.6.2.5 By end user
9.6.2.5.1 Wound care biologics market in hospitals & specialty clinics, by type
Chapter 10. MEA Market Size and Forecast
10.1 By Product
10.1.1 Skin Substitutes Market, by Type
10.1.2 Growth Factors Market, by Type
10.1.3 Cell-Based Wound Care Biologics Market, by Type
10.2 By Durability
10.3 By Formulation
10.4 By Application
10.4.1 Wound Care Biologics Market for Acute Wounds, by Type
10.4.2 Wound Care Biologics Market for Chronic Wounds, by Type
10.5 By End User
10.5.1 Wound Care Biologics Market in Hospitals & Specialty Clinics, by Type
10.6 By Country
10.6.1 Saudi Arabia Market Size and Forecast
10.6.1.1 By product
10.6.1.1.1 Skin substitutes market, by type
10.6.1.1.2 Growth factors market, by type
10.6.1.1.3 Cell-based wound care biologics market, by type
10.6.1.2 By durability
10.6.1.3 By formulation
10.6.1.4 By application
10.6.1.4.1 Wound care biologics market for acute wounds, by type
10.6.1.4.2 Wound care biologics market for chronic wounds, by type
10.6.1.5 By end user
10.6.1.5.1 Wound care biologics market in hospitals & specialty clinics, by type
10.6.2 South Africa Market Size and Forecast
10.6.2.1 By product
10.6.2.1.1 Skin substitutes market, by type
10.6.2.1.2 Growth factors market, by type
10.6.2.1.3 Cell-based wound care biologics market, by type
10.6.2.2 By durability
10.6.2.3 By formulation
10.6.2.4 By application
10.6.2.4.1 Wound care biologics market for acute wounds, by type
10.6.2.4.2 Wound care biologics market for chronic wounds, by type
10.6.2.5 By end user
10.6.2.5.1 Wound care biologics market in hospitals & specialty clinics, by type
10.6.3 Israel Market Size and Forecast
10.6.3.1 By product
10.6.3.1.1 Skin substitutes market, by type
10.6.3.1.2 Growth factors market, by type
10.6.3.1.3 Cell-based wound care biologics market, by type
10.6.3.2 By durability
10.6.3.3 By formulation
10.6.3.4 By application
10.6.3.4.1 Wound care biologics market for acute wounds, by type
10.6.3.4.2 Wound care biologics market for chronic wounds, by type
10.6.3.5 By end user
10.6.3.5.1 Wound care biologics market in hospitals & specialty clinics, by type
Chapter 11. Competitive Landscape
11.1 List of Key Players
11.2 Strategic Developments of Key Players
11.2.1 Product Launches
11.2.2 Mergers and Acquisitions
Chapter 12. Company Profiles
12.1 Smith & Nephew plc
12.1.1 Business Overview
12.1.2 Product and Service Offerings
12.1.3 Key Financial Summary
12.2 Mölnlycke Health Care AB
12.2.1 Business Overview
12.2.2 Product and Service Offerings
12.2.3 Key Financial Summary
12.3 Integra LifeSciences Corporation
12.3.1 Business Overview
12.3.2 Product and Service Offerings
12.3.3 Key Financial Summary
12.4 Wright Medical Group N.V.
12.4.1 Business Overview
12.4.2 Product and Service Offerings
12.5 MiMedx Group Inc.
12.5.1 Business Overview
12.5.2 Product and Service Offerings
12.6 Vericel Corporation
12.6.1 Business Overview
12.6.2 Product and Service Offerings
12.7 Anika Therapeutics Inc.
12.7.1 Business Overview
12.7.2 Product and Service Offerings
12.8 Osiris Therapeutics Inc.
12.8.1 Business Overview
12.8.2 Product and Service Offerings
12.9 Organogenesis Inc.
12.9.1 Business Overview
12.9.2 Product and Service Offerings
12.10 Kerecis Limited
12.10.1 Business Overview
12.10.2 Product and Service Offerings
12.11 Solsys Medical
12.11.1 Business Overview
12.11.2 Product and Service Offerings
12.12 Acell Inc.
12.12.1 Business Overview
12.12.2 Product and Service Offerings
12.13 Marine Polymer Technologies Inc.
12.13.1 Business Overview
12.13.2 Product and Service Offerings
12.14 Skye Biologics Inc.
12.14.1 Business Overview
12.14.2 Product and Service Offerings
Chapter 13. Appendix
13.1 Abbreviations
13.2 Sources and References
13.3 Related Reports
List of Tables
TABLE 1 ANALYSIS PERIOD OF THE STUDY
TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
TABLE 4 WOUND CARE SOCIETIES
TABLE 5 GLOBAL WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)
TABLE 6 GLOBAL WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2025–2030)
TABLE 7 GLOBAL SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)
TABLE 8 GLOBAL SKIN SUBSTITUTES MARKET, BY TYPE, $M (2025–2030)
TABLE 9 GLOBAL GROWTH FACTORS MARKET, BY TYPE, $M (2019–2024)
TABLE 10 GLOBAL GROWTH FACTORS MARKET, BY TYPE, $M (2025–2030)
TABLE 11 GLOBAL CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)
TABLE 12 GLOBAL CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2025–2030)
TABLE 13 GLOBAL WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)
TABLE 14 GLOBAL WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2025–2030)
TABLE 15 GLOBAL WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)
TABLE 16 GLOBAL WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2025–2030)
TABLE 17 GLOBAL WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)
TABLE 18 GLOBAL WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2025–2030)
TABLE 19 GLOBAL WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)
TABLE 20 GLOBAL WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2025–2030)
TABLE 21 GLOBAL WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)
TABLE 22 GLOBAL WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2025–2030)
TABLE 23 GLOBAL WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)
TABLE 24 GLOBAL WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2025–2030)
TABLE 25 GLOBAL WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)
TABLE 26 GLOBAL WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2025–2030)
TABLE 27 GLOBAL WOUND CARE BIOLOGICS MARKET, BY REGION, $M (2019–2024)
TABLE 28 GLOBAL WOUND CARE BIOLOGICS MARKET, BY REGION, $M (2025–2030)
TABLE 29 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)
TABLE 30 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2025–2030)
TABLE 31 NORTH AMERICA SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)
TABLE 32 NORTH AMERICA SKIN SUBSTITUTES MARKET, BY TYPE, $M (2025–2030)
TABLE 33 NORTH AMERICA GROWTH FACTORS MARKET, BY TYPE, $M (2019–2024)
TABLE 34 NORTH AMERICA GROWTH FACTORS MARKET, BY TYPE, $M (2025–2030)
TABLE 35 NORTH AMERICA CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)
TABLE 36 NORTH AMERICA CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2025–2030)
TABLE 37 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)
TABLE 38 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2025–2030)
TABLE 39 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)
TABLE 40 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2025–2030)
TABLE 41 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)
TABLE 42 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2025–2030)
TABLE 43 NORTH AMERICA WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)
TABLE 44 NORTH AMERICA WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2025–2030)
TABLE 45 NORTH AMERICA WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)
TABLE 46 NORTH AMERICA WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2025–2030)
TABLE 47 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)
TABLE 48 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2025–2030)
TABLE 49 WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)
TABLE 50 WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2025–2030)
TABLE 51 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY COUNTRY, $M (2019–2024)
TABLE 52 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY COUNTRY, $M (2025–2030)
TABLE 53 U.S. WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)
TABLE 54 U.S. WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2025–2030)
TABLE 55 U.S. SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)
TABLE 56 U.S. SKIN SUBSTITUTES MARKET, BY TYPE, $M (2025–2030)
TABLE 57 U.S. GROWTH FACTORS MARKET, BY TYPE, $M (2019–2024)
TABLE 58 U.S. GROWTH FACTORS MARKET, BY TYPE, $M (2025–2030)
TABLE 59 U.S. CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)
TABLE 60 U.S. CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2025–2030)
TABLE 61 U.S. WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)
TABLE 62 U.S. WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2025–2030)
TABLE 63 U.S. WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)
TABLE 64 U.S. WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2025–2030)
TABLE 65 U.S. WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)
TABLE 66 U.S. WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2025–2030)
TABLE 67 U.S. WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)
TABLE 68 U.S. WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2025–2030)
TABLE 69 U.S. WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)
TABLE 70 U.S. WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2025–2030)
TABLE 71 U.S. WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)
TABLE 72 U.S. WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2025–2030)
TABLE 73 U.S. WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)
TABLE 74 U.S. WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2025–2030)
TABLE 75 CANADA WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)
TABLE 76 CANADA WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2025–2030)
TABLE 77 CANADA SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)
TABLE 78 CANADA SKIN SUBSTITUTES MARKET, BY TYPE, $M (2025–2030)
TABLE 79 CANADA GROWTH FACTORS MARKET, BY TYPE, $M (2019–2024)
TABLE 80 CANADA GROWTH FACTORS MARKET, BY TYPE, $M (2025–2030)
TABLE 81 CANADA CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)
TABLE 82 CANADA CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2025–2030)
TABLE 83 CANADA WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)
TABLE 84 CANADA WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2025–2030)
TABLE 85 CANADA WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)
TABLE 86 CANADA WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2025–2030)
TABLE 87 CANADA WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)
TABLE 88 CANADA WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2025–2030)
TABLE 89 CANADA WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)
TABLE 90 CANADA WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2025–2030)
TABLE 91 CANADA WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)
TABLE 92 CANADA WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2025–2030)
TABLE 93 CANADA WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)
TABLE 94 CANADA WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2025–2030)
TABLE 95 CANADA WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)
TABLE 96 CANADA WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2025–2030)
TABLE 97 EUROPE WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)
TABLE 98 EUROPE WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2025–2030)
TABLE 99 EUROPE SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)
TABLE 100 EUROPE SKIN SUBSTITUTES MARKET, BY TYPE, $M (2025–2030)
TABLE 101 EUROPE GROWTH FACTORS MARKET, BY TYPE, $M (2019–2024)
TABLE 102 EUROPE GROWTH FACTORS MARKET, BY TYPE, $M (2025–2030)
TABLE 103 EUROPE CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)
TABLE 104 EUROPE CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2025–2030)
TABLE 105 EUROPE WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)
TABLE 106 EUROPE WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2025–2030)
TABLE 107 EUROPE WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)
TABLE 108 EUROPE WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2025–2030)
TABLE 109 EUROPE WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)
TABLE 110 EUROPE WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2025–2030)
TABLE 111 EUROPE WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)
TABLE 112 EUROPE WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2025–2030)
TABLE 113 EUROPE WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)
TABLE 114 EUROPE WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2025–2030)
TABLE 115 EUROPE WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)
TABLE 116 EUROPE WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2025–2030)
TABLE 117 EUROPE WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)
TABLE 118 EUROPE WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2025–2030)
TABLE 119 EUROPE WOUND CARE BIOLOGICS MARKET, BY COUNTRY, $M (2019–2024)
TABLE 120 EUROPE WOUND CARE BIOLOGICS MARKET, BY COUNTRY, $M (2025–2030)
TABLE 121 GERMANY WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)
TABLE 122 GERMANY WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2025–2030)
TABLE 123 GERMANY SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)
TABLE 124 GERMANY SKIN SUBSTITUTES MARKET, BY TYPE, $M (2025–2030)
TABLE 125 GERMANY GROWTH FACTORS MARKET, BY TYPE, $M (2019–2024)
TABLE 126 GERMANY GROWTH FACTORS MARKET, BY TYPE, $M (2025–2030)
TABLE 127 GERMANY CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)
TABLE 128 GERMANY CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2025–2030)
TABLE 129 GERMANY WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)
TABLE 130 GERMANY WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2025–2030)
TABLE 131 GERMANY WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)
TABLE 132 GERMANY WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2025–2030)
TABLE 133 GERMANY WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)
TABLE 134 GERMANY WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2025–2030)
TABLE 135 GERMANY WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)
TABLE 136 GERMANY WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2025–2030)
TABLE 137 GERMANY WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)
TABLE 138 GERMANY WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2025–2030)
TABLE 139 GERMANY WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)
TABLE 140 GERMANY WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2025–2030)
TABLE 141 GERMANY WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)
TABLE 142 GERMANY WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2025–2030)
TABLE 143 FRANCE WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)
TABLE 144 FRANCE WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2025–2030)
TABLE 145 FRANCE SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)
TABLE 146 FRANCE SKIN SUBSTITUTES MARKET, BY TYPE, $M (2025–2030)
TABLE 147 FRANCE GROWTH FACTORS MARKET, BY TYPE, $M (2019–2024)
TABLE 148 FRANCE GROWTH FACTORS MARKET, BY TYPE, $M (2025–2030)
TABLE 149 FRANCE CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)
TABLE 150 FRANCE CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2025–2030)
TABLE 151 FRANCE WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)
TABLE 152 FRANCE WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2025–2030)
TABLE 153 FRANCE WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)
TABLE 154 FRANCE WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2025–2030)
TABLE 155 FRANCE WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)
TABLE 156 FRANCE WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2025–2030)
TABLE 157 FRANCE WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)
TABLE 158 FRANCE WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2025–2030)
TABLE 159 FRANCE WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)
TABLE 160 FRANCE WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2025–2030)
TABLE 161 FRANCE WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)
TABLE 162 FRANCE WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2025–2030)
TABLE 163 FRANCE WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)
TABLE 164 FRANCE WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2025–2030)
TABLE 165 U.K. WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)
TABLE 166 U.K. WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2025–2030)
TABLE 167 U.K. SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)
TABLE 168 U.K. SKIN SUBSTITUTES MARKET, BY TYPE, $M (2025–2030)
TABLE 169 U.K. GROWTH FACTORS MARKET, BY TYPE, $M (2019–2024)
TABLE 170 U.K. GROWTH FACTORS MARKET, BY TYPE, $M (2025–2030)
TABLE 171 U.K. CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)
TABLE 172 U.K. CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2025–2030)
TABLE 173 U.K. WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)
TABLE 174 U.K. WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2025–2030)
TABLE 175 U.K. WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)
TABLE 176 U.K. WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2025–2030)
TABLE 177 U.K. WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)
TABLE 178 U.K. WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2025–2030)
TABLE 179 U.K. WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)
TABLE 180 U.K. WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2025–2030)
TABLE 181 U.K. WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)
TABLE 182 U.K. WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2025–2030)
TABLE 183 U.K. WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)
TABLE 184 U.K. WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2025–2030)
TABLE 185 U.K. WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)
TABLE 186 U.K. WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2025–2030)
TABLE 187 ITALY WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)
TABLE 188 ITALY WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2025–2030)
TABLE 189 ITALY SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)
TABLE 190 ITALY SKIN SUBSTITUTES MARKET, BY TYPE, $M (2025–2030)
TABLE 191 ITALY GROWTH FACTORS MARKET, BY TYPE, $M (2019–2024)
TABLE 192 ITALY GROWTH FACTORS MARKET, BY TYPE, $M (2025–2030)
TABLE 193 ITALY CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)
TABLE 194 ITALY CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2025–2030)
TABLE 195 ITALY WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)
TABLE 196 ITALY WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2025–2030)
TABLE 197 ITALY WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)
TABLE 198 ITALY WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2025–2030)
TABLE 199 ITALY WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)
TABLE 200 ITALY WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2025–2030)
TABLE 201 ITALY WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)
TABLE 202 ITALY WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2025–2030)
TABLE 203 ITALY WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)
TABLE 204 ITALY WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2025–2030)
TABLE 205 ITALY WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)
TABLE 206 ITALY WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2025–2030)
TABLE 207 ITALY WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)
TABLE 208 ITALY WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2025–2030)
TABLE 209 SPAIN WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)
TABLE 210 SPAIN WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2025–2030)
TABLE 211 SPAIN SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)
TABLE 212 SPAIN SKIN SUBSTITUTES MARKET, BY TYPE, $M (2025–2030)
TABLE 213 SPAIN GROWTH FACTORS MARKET, BY TYPE, $M (2019–2024)
TABLE 214 SPAIN GROWTH FACTORS MARKET, BY TYPE, $M (2025–2030)
TABLE 215 SPAIN CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)
TABLE 216 SPAIN CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2025–2030)
TABLE 217 SPAIN WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)
TABLE 218 SPAIN WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2025–2030)
TABLE 219 SPAIN WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)
TABLE 220 SPAIN WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2025–2030)
TABLE 221 SPAIN WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)
TABLE 222 SPAIN WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2025–2030)
TABLE 223 SPAIN WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)
TABLE 224 SPAIN WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2025–2030)
TABLE 225 SPAIN WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)
TABLE 226 SPAIN WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2025–2030)
TABLE 227 SPAIN WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)
TABLE 228 SPAIN WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2025–2030)
TABLE 229 SPAIN WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)
TABLE 230 SPAIN WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2025–2030)
TABLE 231 APAC WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)
TABLE 232 APAC WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2025–2030)
TABLE 233 APAC SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)
TABLE 234 APAC SKIN SUBSTITUTES MARKET, BY TYPE, $M (2025–2030)
TABLE 235 APAC GROWTH FACTORS MARKET, BY TYPE, $M (2019–2024)
TABLE 236 APAC GROWTH FACTORS MARKET, BY TYPE, $M (2025–2030)
TABLE 237 APAC CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)
TABLE 238 APAC CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2025–2030)
TABLE 239 APAC WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)
TABLE 240 APAC WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2025–2030)
TABLE 241 APAC WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)
TABLE 242 APAC WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2025–2030)
TABLE 243 APAC WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)
TABLE 244 APAC WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2025–2030)
TABLE 245 APAC WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)
TABLE 246 APAC WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2025–2030)
TABLE 247 APAC WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)
TABLE 248 APAC WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2025–2030)
TABLE 249 APAC WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)
TABLE 250 APAC WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2025–2030)
TABLE 251 APAC WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)
TABLE 252 APAC WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2025–2030)
TABLE 253 APAC WOUND CARE BIOLOGICS MARKET, BY COUNTRY, $M (2019–2024)
TABLE 254 APAC WOUND CARE BIOLOGICS MARKET, BY COUNTRY, $M (2025–2030)
TABLE 255 CHINA WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)
TABLE 256 CHINA WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2025–2030)
TABLE 257 CHINA SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)
TABLE 258 CHINA SKIN SUBSTITUTES MARKET, BY TYPE, $M (2025–2030)
TABLE 259 CHINA GROWTH FACTORS MARKET, BY TYPE, $M (2019–2024)
TABLE 260 CHINA GROWTH FACTORS MARKET, BY TYPE, $M (2025–2030)
TABLE 261 CHINA CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)
TABLE 262 JAPAN CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2025–2030)
TABLE 263 CHINA WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)
TABLE 264 CHINA WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2025–2030)
TABLE 265 CHINA WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)
TABLE 266 CHINA WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2025–2030)
TABLE 267 CHINA WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)
TABLE 268 CHINA WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2025–2030)
TABLE 269 CHINA WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)
TABLE 270 CHINA WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2025–2030)
TABLE 271 CHINA WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)
TABLE 272 CHINA WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2025–2030)
TABLE 273 CHINA WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)
TABLE 274 CHINA WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2025–2030)
TABLE 275 CHINA WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)
TABLE 276 CHINA WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2025–2030)
TABLE 277 JAPAN WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)
TABLE 278 JAPAN WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2025–2030)
TABLE 279 JAPAN SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)
TABLE 280 JAPAN SKIN SUBSTITUTES MARKET, BY TYPE, $M (2025–2030)
TABLE 281 JAPAN GROWTH FACTORS MARKET, BY TYPE, $M (2019–2024)
TABLE 282 JAPAN GROWTH FACTORS MARKET, BY TYPE, $M (2025–2030)
TABLE 283 JAPAN CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)
TABLE 284 JAPAN CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2025–2030)
TABLE 285 JAPAN WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)
TABLE 286 JAPAN WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2025–2030)
TABLE 287 JAPAN WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)
TABLE 288 JAPAN WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2025–2030)
TABLE 289 JAPAN WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)
TABLE 290 JAPAN WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2025–2030)
TABLE 291 JAPAN WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)
TABLE 292 JAPAN WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2025–2030)
TABLE 293 JAPAN WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)
TABLE 294 JAPAN WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2025–2030)
TABLE 295 JAPAN WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)
TABLE 296 JAPAN WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2025–2030)
TABLE 297 JAPAN WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)
TABLE 298 JAPAN WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2025–2030)
TABLE 299 INDIA WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)
TABLE 300 INDIA WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2025–2030)
TABLE 301 INDIA SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)
TABLE 302 INDIA SKIN SUBSTITUTES MARKET, BY TYPE, $M (2025–2030)
TABLE 303 INDIA GROWTH FACTORS MARKET, BY TYPE, $M (2019–2024)
TABLE 304 INDIA GROWTH FACTORS MARKET, BY TYPE, $M (2025–2030)
TABLE 305 INDIA CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)
TABLE 306 INDIA CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2025–2030)
TABLE 307 INDIA WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)
TABLE 308 INDIA WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2025–2030)
TABLE 309 INDIA WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)
TABLE 310 INDIA WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2025–2030)
TABLE 311 INDIA WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)
TABLE 312 INDIA WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2025–2030)
TABLE 313 INDIA WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)
TABLE 314 INDIA WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2025–2030)
TABLE 315 INDIA WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)
TABLE 316 INDIA WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2025–2030)
TABLE 317 INDIA WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)
TABLE 318 INDIA WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2025–2030)
TABLE 319 INDIA WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)
TABLE 320 INDIA WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2025–2030)
TABLE 321 AUSTRALIA WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)
TABLE 322 AUSTRALIA WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2025–2030)
TABLE 323 AUSTRALIA SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)
TABLE 324 AUSTRALIA SKIN SUBSTITUTES MARKET, BY TYPE, $M (2025–2030)
TABLE 325 AUSTRALIA GROWTH FACTORS MARKET, BY TYPE, $M (2019–2024)
TABLE 326 AUSTRALIA GROWTH FACTORS MARKET, BY TYPE, $M (2025–2030)
TABLE 327 AUSTRALIA CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)
TABLE 328 AUSTRALIA CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2025–2030)
TABLE 329 AUSTRALIA WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)
TABLE 330 AUSTRALIA WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2025–2030)
TABLE 331 AUSTRALIA WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)
TABLE 332 AUSTRALIA WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2025–2030)
TABLE 333 AUSTRALIA WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)
TABLE 334 AUSTRALIA WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2025–2030)
TABLE 335 AUSTRALIA WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)
TABLE 336 AUSTRALIA WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2025–2030)
TABLE 337 AUSTRALIA WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)
TABLE 338 AUSTRALIA WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2025–2030)
TABLE 339 AUSTRALIA WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)
TABLE 340 AUSTRALIA WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2025–2030)
TABLE 341 AUSTRALIA WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)
TABLE 342 AUSTRALIA WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2025–2030)
TABLE 343 LATAM WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)
TABLE 344 LATAM WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2025–2030)
TABLE 345 LATAM SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)
TABLE 346 LATAM SKIN SUBSTITUTES MARKET, BY TYPE, $M (2025–2030)
TABLE 347 LATAM GROWTH FACTORS MARKET, BY TYPE, $000’ (2019–2024)
TABLE 348 LATAM GROWTH FACTORS MARKET, BY TYPE, $000’ (2025–2030)
TABLE 349 LATAM CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)
TABLE 350 LATAM CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2025–2030)
TABLE 351 LATAM WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)
TABLE 352 LATAM WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2025–2030)
TABLE 353 LATAM WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)
TABLE 354 LATAM WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2025–2030)
TABLE 355 LATAM WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)
TABLE 356 LATAM WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2025–2030)
TABLE 357 LATAM WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)
TABLE 358 LATAM WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2025–2030)
TABLE 359 LATAM WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)
TABLE 360 LATAM WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2025–2030)
TABLE 361 LATAM WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)
TABLE 362 LATAM WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2025–2030)
TABLE 363 LATAM WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)
TABLE 364 LATAM WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2025–2030)
TABLE 365 LATAM WOUND CARE BIOLOGICS MARKET, BY COUNTRY, $M (2019–2024)
TABLE 366 LATAM WOUND CARE BIOLOGICS MARKET, BY COUNTRY, $M (2025–2030)
TABLE 367 MEXICO WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2019–2024)
TABLE 368 MEXICO WOUND CARE BIOLOGICS MARKET, BY PRODUCT, $M (2025–2030)
TABLE 369 MEXICO SKIN SUBSTITUTES MARKET, BY TYPE, $M (2019–2024)
TABLE 370 MEXICO SKIN SUBSTITUTES MARKET, BY TYPE, $M (2025–2030)
TABLE 371 MEXICO GROWTH FACTORS MARKET, BY TYPE, $000’ (2019–2024)
TABLE 372 MEXICO GROWTH FACTORS MARKET, BY TYPE, $000’ (2025–2030)
TABLE 373 MEXICO CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2019–2024)
TABLE 374 MEXICO CELL-BASED WOUND CARE BIOLOGICS MARKET, BY TYPE, $M (2025–2030)
TABLE 375 MEXICO WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2019–2024)
TABLE 376 MEXICO WOUND CARE BIOLOGICS MARKET, BY DURABILITY, $M (2025–2030)
TABLE 377 MEXICO WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2019–2024)
TABLE 378 MEXICO WOUND CARE BIOLOGICS MARKET, BY FORMULATION, $M (2025–2030)
TABLE 379 MEXICO WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2019–2024)
TABLE 380 MEXICO WOUND CARE BIOLOGICS MARKET, BY APPLICATION, $M (2025–2030)
TABLE 381 MEXICO WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2019–2024)
TABLE 382 MEXICO WOUND CARE BIOLOGICS MARKET FOR ACUTE WOUNDS, BY TYPE, $M (2025–2030)
TABLE 383 MEXICO WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2019–2024)
TABLE 384 MEXICO WOUND CARE BIOLOGICS MARKET FOR CHRONIC WOUNDS, BY TYPE, $M (2025–2030)
TABLE 385 MEXICO WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2019–2024)
TABLE 386 MEXICO WOUND CARE BIOLOGICS MARKET, BY END USER, $M (2025–2030)
TABLE 387 MEXICO WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE, $M (2019–2024)
TABLE 388 MEXICO WOUND CARE BIOLOGICS MARKET IN HOSPITALS & SPECIALTY CLINICS, BY TYPE
Want a report tailored exactly to your business strategy?
Request CustomizationWant an insight-rich discussion with the report author?
Speak to Analyst
Our dedication to providing the most-accurate market information has earned us verification by Dun & Bradstreet (D&B). We strive for quality checking of the highest level to enable data-driven decision making for you
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
With 24/7 research support, we ensure that the wheels of your business never stop turning. Don’t let time stand in your way. Get all your queries answered with a simple phone call or email, as and when required
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws